ArticleEuropean journal of pediatrics2026
Longitudinal post-discharge growth according to bronchopulmonary dysplasia severity in very preterm infants: a cohort study.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate the association between bronchopulmonary dysplasia (BPD) severity and post-discharge growth during the first year of corrected age in very preterm infants, including recovery from established growth failure at hospital discharge. This retrospective cohort included 1,106 infants born before 32 weeks' gestation, classified using the Jensen BPD definition as no BPD (n = 768), mild (n = 142), moderate (n = 154), or severe BPD (n = 42). Weight, length, and head circumference z-scores were assessed from birth to 12 months corrected age. Longitudinal growth trajectories and time to recovery from discharge growth failure were evaluated using adjusted models. Increasing BPD severity was associated with progressively poorer anthropometric outcomes at discharge and 12 months (all p < 0.001). At 12 months, severe BPD remained independently associated with lower weight (β - 0.596, 95% CI - 1.134 to - 0.057; p = 0.030), length (β - 0.800, 95% CI - 1.443 to - 0.156; p = 0.015), and head circumference (β - 1.177, 95% CI - 2.001 to - 0.353; p = 0.005) z-scores. Among infants with growth failure at discharge, severe BPD was associated with slower recovery of weight (HR 0.40, 95% CI 0.19-0.81; p = 0.011), length (HR 0.25, 95% CI 0.14-0.48; p < 0.001), and head circumference (HR 0.23, 95% CI 0.08-0.72; p = 0.012). Median recovery was not reached for any anthropometric domain in severe BPD; corresponding 12-month recovery probabilities were 41.3%, 42.6%, and 30.1%, respectively. Conclusion: Severe BPD was independently associated with persistent impairment in weight, length, and head circumference and substantially delayed recovery from established growth failure during infancy. These findings support structured longitudinal growth monitoring and targeted nutritional follow-up after discharge.
Indexed as
Identifiers
42844452What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.